DUBLIN--(BUSINESS WIRE)--The "Global Atherectomy Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with occlusive lower extremity peripheral artery disease treated with atherectomy devices ...

DUBLIN--(BUSINESS WIRE)--The "U.S. Atherectomy Devices Market Size, Share & Trends Analysis Report By Type (Laser, Directional, Rotational, Orbital), By End Use (Office-based Labs, Out-patient ...

Growing demand in major states like California, New York, and New Jersey, supported by robust healthcare networks and reimbursement policies, is set to propel market growth U.S. Atherectomy Devices ...

Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...

For patients with peripheral arterial disease, the mainstay of initial treatment is always risk factor modification, ambulation, and compliance with guideline-based medical therapies. However, for ...

The proliferation of outpatient and ambulatory surgical centers has further enhanced the accessibility of atherectomy procedures, creating a favorable environment for market expansion. Despite this ...

Real-world data from a large registry show conclusive evidence that atherectomy in conjunction with angioplasty can have tangible survival and limb-saving benefits for patients with peripheral ...

REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne ...

HOLLYWOOD, FL—A distal embolic protection device already approved by the US Food and Drug Administration (FDA) for use in carotid artery stenting can also be applied safely in patients undergoing ...

WASHINGTON, DC — Atherectomy has no advantage over conventional balloon angioplasty for the treatment of severe calcified lesions, according to unexpected results from the largest trial of the ...

REDWOOD CITY, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that the Company ...